Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition. The shortlist includes our DPhil student Magda Mareckova (pictured).

Good luck to our DPhil student Magda Mareckova. Her article: “One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?” is shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition.

Latest news

NPEU colleagues contribute to new book on race and health inequity

The paperback edition of Understanding Race and Health Inequity in the UK, featuring contributions from NPEU colleagues in the Nuffield Department of Women’s & Reproductive Health (NDWRH), was published on 3 August.

NPEU research highlighted in Guardian commentary on maternity care reform

NPEU research has been highlighted in The Guardian as important evidence for informing the next steps in maternity care reform. The article draws on NPEU work on maternity experiences, maternal mortality and caesarean birth rates, emphasising the need for robust evidence and partnership with women and families to support safer, more equitable maternity care.

Register for our MSc Virtual Open Events

Thinking about postgraduate study at Oxford? Join one of our upcoming Virtual Open Events to discover our MSc programmes in Clinical Embryology and Reproductive Genetics, meet the course teams and find out more about studying with us in 2027–28.

Patient enrolment begins in PARTNERS trial which aims to evaluate treatments for the Bundibugyo virus

The first patient has been enrolled in the PARTNERS trial, which will evaluate potential treatments for the Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo.

Our Research Groups